FAM
BIO icon

Formidable Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Formidable Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,464
Closed -$701K – 299
2023
Q1 		$701K Buy
1,464
+531
+57% +$249K 0.15% 134
2022
Q4 		$392K Hold
933
– – 0.09% 192
2022
Q3 		$389K Buy
933
+22
+2% +$11K 0.09% 186
2022
Q2 		$451K Buy
911
+15
+2% +$7.81K 0.1% 179
2022
Q1 		$505K Buy
896
+56
+7% +$33.8K 0.1% 183
2021
Q4 		$635K Buy
840
+84
+11% +$62.9K 0.12% 156
2021
Q3 		$564K Buy
+756
New +$566K 0.11% 182

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Formidable Asset Management's BIO Position: Q2 2023 in Review

Formidable Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 1,464 shares — an estimated $701K sold.

Formidable Asset Management first reported a position in BIO in Q3 2021 and held it in 7 quarters. The position peaked at $701K in Q1 2023. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Formidable Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Formidable Asset Management sold 1,464 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $701K.
  • Formidable Asset Management first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and held it in 7 quarters.
  • Formidable Asset Management's Bio-Rad Laboratories Class A position peaked at $701K in Q1 2023.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Formidable Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.